ImmunoPrecise Antibodies Ltd (IPA)
0.4001
-0.02
(-4.76%)
USD |
NASDAQ |
Dec 20, 16:00
0.4014
0.00 (0.00%)
After-Hours: 20:00
ImmunoPrecise Antibodies Shareholders Equity (Quarterly): 23.49M for Oct. 31, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 388.00M |
| Edesa Biotech Inc | 1.981M |
| Lexaria Bioscience Corp | 8.036M |
| Xenon Pharmaceuticals Inc | 797.81M |
| ESSA Pharma Inc | 124.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.11M |
| Total Liabilities (Quarterly) | 19.62M |
| Debt to Equity Ratio | 0.0947 |
| Current Ratio | 1.008 |
| Net Debt Paydown Yield | -3.08% |